Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

DA Davidson Maintains Neutral on Expedia Group, Raises Price Target to $121

DA Davidson analyst Tom White maintains Expedia Group (NASDAQ:EXPE) with a Neutral and raises the price target from $108 to $121.

byBenzinga Newsdesk

March 3, 2023

1 minute read

DA Davidson analyst Tom White maintains Expedia Group (NASDAQ:EXPE) with a Neutral and raises the price target from $108 to $121.

Goldman Sachs Maintains Sell on Coinbase Global, Lowers Price Target to $30

By Benzinga Newsdesk

Today, 9:53 PM

Goldman Sachs analyst Will Nance maintains Coinbase Global (NASDAQ:COIN) with a Sell and lowers the price target from $41 to $30.

COIN

Citigroup Downgrades Brookfield Asset Mgmt to Neutral, Lowers Price Target to $61

By Benzinga Newsdesk

Today, 9:53 PM

Citigroup analyst William Katz downgrades Brookfield Asset Mgmt (NYSE:BAM) from Buy to Neutral and lowers the price target from $68.5 to $61.

BAM

M&A
News

Holocene Advisors Says Believes Merck’s Proposed Offer of $180 Per Share for Acceleron Significantly Undervalues Company

By Michael Horton

Today, 9:53 PM

Long-term Holder Does Not Intend to Tender Shares into Merck's Offer Holocene Advisors, LP ("Holocene"), a fundamental investment management firm and significant shareholder of Acceleron Pharma Inc.

MRK

Morgan Stanley Maintains Underweight on Intel, Lowers Price Target to $36

By Benzinga Newsdesk

Today, 9:53 PM

Morgan Stanley analyst Joshua Pokrzywinski maintains Intel (NASDAQ:INTC) with a Underweight and lowers the price target from $46 to $36.

INTC

DA Davidson Maintains Neutral on Expedia Group, Raises Price Target to $121

Related Posts

Goldman Sachs Maintains Sell on Coinbase Global, Lowers Price Target to $30

Citigroup Downgrades Brookfield Asset Mgmt to Neutral, Lowers Price Target to $61

Holocene Advisors Says Believes Merck’s Proposed Offer of $180 Per Share for Acceleron Significantly Undervalues Company

Morgan Stanley Maintains Underweight on Intel, Lowers Price Target to $36